Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00262301
Status:
COMPLETED
Last Update Posted:
2012-10-02
First Post:
2005-12-01
Brief Title:
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
Sponsor:
Pharming Technologies BV
Organization:
Pharming Technologies BV
Organization Data
Organization:
Pharming Technologies BV
Class:
INDUSTRY
Study ID:
C1 1304-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pharming Technologies BV
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None